Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.
about
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patientsMicrosatellite instability in colorectal cancerMolecular alterations and biomarkers in colorectal cancerPrediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics.Role of Deficient Mismatch Repair in the Personalized Management of Colorectal CancerClinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.Genetic testing for hereditary colorectal cancer.Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.Simplified microsatellite instability detection protocol provides equivalent sensitivity to robust detection strategies in Lynch syndrome patients.DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.Heterogenous mismatch-repair status in colorectal cancer.Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto RicoEvaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.Application of molecular diagnostics for the detection of Lynch syndrome.Colorectal cancer molecular biology moves into clinical practice.Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats.Absence of microsatellite instability in mucinous carcinomas of the breast.Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patientsCirculating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.New facial papules in a 66-year-old woman with bladder cancerAssociation between molecular subtypes of colorectal cancer and patient survivalQuality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family RegistrySystematic study on genetic and epimutational profile of a cohort of Amsterdam criteria-defined Lynch Syndrome in Singapore.Immunohistochemical analysis of mismatch repair proteins in Iranian colorectal cancer patients at risk for lynch syndromeLynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia.Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?Advances in the study of Lynch syndrome in ChinaIdentification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing.Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.Influence of patient preferences on the cost-effectiveness of screening for lynch syndromeMolecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancerCombination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
P2860
Q21328691-55373147-8118-4388-BF2E-457B1BA533CFQ24627393-29F1AC0F-E3C2-4242-A019-0C273CE2920EQ26862317-B7E2A2DC-11A7-4A21-BE54-F0DD6FDB603AQ27347219-0E07EAF3-8CFB-40A6-BB6D-2B6E74E6AECCQ28080176-9BB5F54C-A9F6-4250-A247-A814396E5296Q30275239-F64F64DA-5AC8-445D-8F67-51AD80A7AC6CQ33649978-4604A085-7F46-4D5D-B16B-034F4DA602CBQ33653935-C8730AD9-B48A-4C82-9F72-EE99AFB1A8DEQ33728916-0742E262-61E7-418E-8F18-DCF6239A88B6Q33754229-BAE86912-0211-42BC-8FBA-E79FD9AE989EQ33775296-6DD9546A-C080-42BC-937E-8B24597F1B03Q33820382-8A71C3A9-3865-44A2-BB1B-D42E43AD6054Q33862772-9EA345F9-85E5-4318-93FA-B4FF367CAE5AQ33874719-50622013-A864-4C51-BEFC-05CF72FD87ABQ33939068-B341935B-C44B-4D44-AD52-43C763DB1202Q34023517-5B0C8BFA-6851-4D8C-8A79-E5E467D8E838Q34088809-142BEDB4-4B2D-44C1-AC38-0EFA71EC3578Q34425013-4619C47E-BE2B-47A7-904E-C85829521EE9Q34433799-F59A86B6-39DB-40ED-91E7-D56D0D5CDF82Q34467216-A75091CF-258E-4E4B-92C5-CE98F537FD9CQ34477375-0D2A973F-2C3C-43CB-BA7D-B625401969C8Q34533164-D5341FAC-BCE7-49CC-AA1D-3B6EA11C740DQ34620160-314118C4-9971-4D9A-836E-CF2E4F55B157Q34759064-FE923FBA-3999-4803-A3B5-F63BEEF2729BQ34801092-53CDA04F-3B0A-4EDA-9B7C-2A800D0CCB56Q35013990-564C3078-482E-45AE-BD2D-49A45F772D83Q35063442-27B1ECEB-B715-4F0C-9AB7-7835EA4A9C6AQ35112612-B4B18B56-E78F-412A-A43F-8BA173C0F7D6Q35141950-C3182AE8-C29F-466D-82A9-E886E19BFE1CQ35179173-D8F3451D-F17D-40F7-8ACC-8FFC1FD9CADFQ35181103-4555CC99-EC83-461F-8FBA-89D6B131D8F1Q35198210-299AA1F9-6234-4307-8467-DD4927DDA116Q35234577-ABDC81AE-A3F3-4244-8DDE-72DD13FF1418Q35469854-5785735E-E5F3-43FD-B001-550E00755A56Q35716138-7B7FD6E1-1708-465B-926F-22BC6AE74268Q35740291-98546727-1D1F-466E-9D12-9451EC600003Q35741131-63D96480-0BD2-413B-BD9D-C90FEE588675Q35947752-29AE68F4-0F23-4035-AF81-E51711BAC235Q36057058-B1CC2C01-0DDA-434E-985C-4AD3C057B915Q36086848-876A4E64-F175-45C5-BDF4-96B94256B95F
P2860
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immunohistochemistry versus mi ...... ility of immunohistochemistry.
@en
Immunohistochemistry versus mi ...... ility of immunohistochemistry.
@nl
type
label
Immunohistochemistry versus mi ...... ility of immunohistochemistry.
@en
Immunohistochemistry versus mi ...... ility of immunohistochemistry.
@nl
prefLabel
Immunohistochemistry versus mi ...... ility of immunohistochemistry.
@en
Immunohistochemistry versus mi ...... ility of immunohistochemistry.
@nl
P2860
P921
P1476
Immunohistochemistry versus mi ...... ility of immunohistochemistry.
@en
P2860
P304
P356
10.2353/JMOLDX.2008.080031
P50
P577
2008-06-13T00:00:00Z